IMMUDEX
LIVE

Serial Number

88019409

Owner

Immudex ApS

Attorney

Miriam D. Trudell

Filing Date

Jun 28, 2018

Add to watchlist:

No watchlists yet
View on USPTO

IMMUDEX Trademark

Serial Number: 88019409 • Registration: 6031798

IMMUDEX is a trademark filed by Immudex ApS on June 28, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Immudex ApS (8 trademarks)

Bredevej 2A

Entity Type: 99

Trademark Details

Filing Date

June 28, 2018

Registration Date

April 14, 2020

Published for Opposition

January 14, 2020

Goods & Services

Scientific research services; diagnostic services related to scientific research; basic research and clinical research in relation to medicine and vaccine development; research and development in the field of diagnostic preparations

Chemicals used in diagnostics, industry and science, other than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagents, monoclonal antibodies, reagents, diagnostic agents, control reagents, DNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for analysis for research purposes of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis for research purposes of infectious diseases, autoimmunity and for use in connection with toxicological studies and research in relation to transplantation, immune monitoring, vaccines and T-cell monitoring; chemical reagents other than for medicinal and veterinary purposes

Preparations for pharmaceutical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccines, immunotherapeutics and cellular therapies, including cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy and other medical therapies, for analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases, and for use in connection with medical procedures and diagnosis, namely transplantation, immune monitoring, and vaccines and T-cell monitoring

Filing History

TEAS SECTION 8 & 15 RECEIVED
Mar 31, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 14, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 9, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 9, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 9, 2024 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 12, 2024 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 12, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 14, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 14, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 14, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 14, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 14, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 14, 2023 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 16, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 16, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 16, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 16, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 16, 2021 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 12, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 12, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 12, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 12, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 12, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 12, 2021 COAR
REGISTERED-PRINCIPAL REGISTER
Apr 14, 2020 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Mar 11, 2020 DP1B
NOTICE OF ALLOWANCE CANCELLED
Mar 11, 2020 IUCN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 10, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jan 14, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 7, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 22, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 24, 2019 GNFN
FINAL REFUSAL E-MAILED
May 24, 2019 GNFR
FINAL REFUSAL WRITTEN
May 24, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2019 CRFA
ASSIGNED TO LIE
May 6, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 25, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 25, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 25, 2019 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 26, 2018 GNRN
NON-FINAL ACTION E-MAILED
Oct 26, 2018 GNRT
NON-FINAL ACTION WRITTEN
Oct 26, 2018 CNRT
ASSIGNED TO EXAMINER
Oct 18, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 3, 2018 NWOS
NEW APPLICATION ENTERED
Jul 2, 2018 NWAP